Social

Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa

The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.

Social

Feb 14, 2025

Harbin Asian Winter Games: Ensuring Athletes to Safely Compete on the Ice

HARBIN,China,Feb. 13,2025-- On February 7,2025,the 9th Asian Winter Games (AWG) officially kicked off in Harbin,marking the largest edition of the event in history,with over 1,200 athletes from 34 cou

Social

Feb 14, 2025

AI is turbocharging media production and democratizing creativity, but challenges persist for the industry, reveals new MIT Technology Review Insights research report

Digital media standards underlie every advance CAMBRIDGE,Mass.,Feb. 13,2025-- A new report byMIT Technology Review Insights explores how emerging tech is remaking the media and entertainment industri

Social

Feb 14, 2025

ABI Research Unveils 66 Must-Know Tech Stats for 2025 Highlighting Key Markets on the Rise and Decline

NEW YORK,Feb. 13,2025-- In an era of rapid digital transformation,global technology intelligence firm ABI Research has released its highly anticipated 66 Must-Know Tech Stats for 2025: Markets on the

Social

Feb 14, 2025

Lockton Launches Digital Office to be Led by Claude Yoder

KANSAS CITY,Mo.,Feb. 13,2025-- Lockton,the world\'s largest independent insurance brokerage,is pleased to announce the establishment of a Digital Office to drive innovation in data,analytics,and tech

Social

Feb 14, 2025

Regal Hotels Leverages Network to Support Hong Kong's Healthcare Professionals with an Exclusive Long-stay Accommodation Programme

HONG KONG,Feb. 13,2025-- Regal Hotels International is leveraging its extensive hotel network to launch the exclusive "Long-stay Accommodation Programme" for Hospital Authority (HA) staff.

Social

Feb 14, 2025

1 ... 91 92 93 94 95 96 97 ... 136